William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
Riverside Toasts Successful Exit of E&A Scheer
-
Riverside Toasts Successful Exit of E&A Scheer
-
Aehr Reports Strong Revenue and Earnings Growth for the Second Quarter and First Six Months of Fiscal 2024
-
William Blair Upgrades Beacon Roofing Supply (BECN) to Outperform
-
Holding(s) in Company
-
Form 40-17G WILLIAM BLAIR FUNDS
-
Houlihan Lokey (HLI) Appoints Dudley Baker and Kerr Robertson as Managing Directors
-
Houlihan Lokey Expands Healthcare Group With Two Senior Hires
-
Vance Street and Micronics Complete Strategic Acquisition of SOLAFT® Filtration Solutions
-
McNally Capital to Sell Advanced Micro Instruments, Inc. to Enpro Inc.
-
Avathon Capital Sells Big Blue Marble Academy to Leeds Equity Partners
-
Analysis-Emerging markets brace for wave of elections with fiscal discipline at stake
-
Leeds Equity Partners Acquires Big Blue Marble Academy
-
William Blair Starts Enovis Corp (ENOV) at Outperform, 'attractive valuation'
-
US FDA approvals bounce back in 2023, sparking hopes of a biotech recovery
-
William Blair sees UiPath Inc. (PATH) 'getting a boost from AI'
-
Myers Industries (MYE) Announces Acquisition of Signature Systems
-
Myers Industries Announces Acquisition of Signature Systems
-
William Blair Starts UiPath Inc. (PATH) at Outperform, 'leadership position in a large market for automation technology'
-
Pinstripes (PNST) Completes Business Combination with Banyan Acquisition Corporation (BYN) and Will Begin Trading on NYSE
-
Pinstripes Completes Business Combination with Banyan Acquisition Corporation and Will Begin Trading on New York Stock Exchange
-
William Blair expects lululemon athletica (LULU) holiday sales to be robust
-
Lululemon Athletica Inc. (LULU) Mentioned Positively at William Blair, 'Raising Estimates on Expectation of Robust Holiday Sales'
-
Bristol Myers to buy RayzeBio for $4.1 billion in targeted cancer therapy push
-
Angola's OPEC exit opens way for more Chinese investment
-
Bristol Myers to buy schizophrenia drugmaker Karuna Therapeutics for $14 billion
-
Vance Street Capital Raises Continuation Fund to Support Continued Growth of Jet Parts Engineering
-
Emerging market debt wall looks scalable as investors warm to risk
-
William Blair Starts J.Jill Inc. (JILL) at Outperform
-
William Blair's top large cap picks for 2024
-
SKYSERVICE COMPLETES INVESTMENT IN FONTAINEBLEAU AVIATION
-
William Blair Upgrades Allakos Inc. (ALLK) to Outperform, 'potential to be a best-in-class therapy'
-
Palantir (PLTR) wins $115 Million U.S. Army contract extension, analysts divided on impact
-
TREND Health Partners Acquires Advent Health Partners
-
Hypergene Announces Growth Investment from Thoma Bravo
-
Vivid Seats Announces Closing of Secondary Offering and Share Repurchase, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
Chicago Pacific Founders Welcomes Sam Bendix as a Healthcare Real Estate & Infrastructure Partner
-
Stubbornly high rental costs lift US consumer inflation in November
-
William Blair Reiterates Underperform Rating on Palantir (PLTR), 'We Continue to Forecast the Vantage Renewal Value Will Be Less Than $458 Million'
-
Vivid Seats Announces Pricing of Secondary Offering and Repurchase of Class A Common Stock
-
Solid US job growth, drop in unemployment rate underscore labor market resilience
-
Alentis Therapeutics Expands Leadership Team with the Appointment of Rizwan Velji as Chief Business Officer
-
SharkNinja (SN) prices 6.095M share secondary offering at $47
-
SharkNinja Announces Pricing of Secondary Offering of Ordinary Shares
-
SoundThinking Sets Upcoming Financial Conference Schedule
-
Prominent Anesthesiologist & Healthcare Executive Joins Surgical Directions' Strategic Advisory Board
-
Carvana (CVNA) Demonstrates Operational Efficiency, Process Scalability, and Capacity for Growth During Investor Tour
-
Carvana Demonstrates Operational Efficiency, Process Scalability, and Capacity for Growth During Investor Tour
-
General Atlantic Announces 2023 Promotions
-
William Blair Starts VistaGen Therapeutics (VTGN) at Outperform, 'Delivering on an Underappreciated CNS Pipeline'

